Tadalafil monotherapy is a reasonable alternative for the treatment of lower urinary tract symptoms in patients with comorbid benign prostatic hyperplasia and erectile dysfunction

Key Points

• To evaluate the effectiveness of tadalafil monotherapy for treating lower urinary tract symptoms in patients with benign prostatic hyperplasia and erectile dysfunction.
• Conducted an international, randomized, parallel, placebo-controlled clinical trial.
• Compared the effects of tadalafil and tamsulosin on urinary tract symptoms.
• Focused on a patient population with comorbid benign prostatic hyperplasia and erectile dysfunction.
• Both tadalafil and tamsulosin similarly improved lower urinary tract symptoms.
• Tadalafil was a suitable alternative for patients who discontinued dutasteride due to side effects.